VIVAIRE pressurised inhalation 100mcg/6mcg x 120 doses
Asthma
Viver is indicated for the regular treatment of asthma when the use of combination medicinal products (inhaled corticosteroids and long-acting beta2-agonists) is appropriate in:
- patients who do not achieve adequate control of symptoms with inhaled corticosteroids or, as needed, inhaled short-acting beta2-agonists; or
- patients who are adequately controlled with a combination of inhaled corticosteroids and long-acting beta2-agonists.
COPD
Symptomatic treatment of patients with severe chronic obstructive pulmonary disease (COPD) (FEV1 < 50% predicted normal) and a history of multiple exacerbations who have severe symptoms despite regular treatment with long-acting bronchodilators.
Composition:
100 micrograms beclometasone dipropionate; 6 micrograms formoterol fumarate dihydrate